Under the metabolic rheostat framework, SQOR expression and activity are highly context-dependent: upregulation protects tissues from ischemia/reperfusion injury and ferroptosis, whereas inhibition may be beneficial in chronic heart failure or early cancer by allowing endogenous H2S to accumulate. Here, SQOR is linked to congestive heart failure.